Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2412]

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

Novel blood-based protein signature determined for rare, aggressive lung cancer

Novel blood-based protein signature determined for rare, aggressive lung cancer

Defects in epithelial barriers drive colorectal cancer growth

Defects in epithelial barriers drive colorectal cancer growth

ESMO 2012: New findings highlight the challenges of managing blood clotting in cancer patients

ESMO 2012: New findings highlight the challenges of managing blood clotting in cancer patients

ESMO 2012: Most cancer patients prepared to delay treatment to benefit from personalised care

ESMO 2012: Most cancer patients prepared to delay treatment to benefit from personalised care

ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

Predicting erectile dysfunction from prostate cancer treatment

Predicting erectile dysfunction from prostate cancer treatment

MRI helps identify patients with prostate cancer who may benefit from active surveillance

MRI helps identify patients with prostate cancer who may benefit from active surveillance

Study sheds light on causes of male breast cancer

Study sheds light on causes of male breast cancer

Double assault on tough types of leukaemias

Double assault on tough types of leukaemias

More from ecancer